“Some epidemiologic studies have shown a positive correlation between the consumption of soft drinks and the incidence of cardiovascular disease (CVD) and stroke, while other reports have demonstrated that the intake of green tea and coffee reduced the risk and mortality of CVD,” said principal investigator Professor Keijiro Saku, Dean and professor of cardiology at Fukuoka University in Japan. “Carbonated beverages, or sodas, have frequently been demonstrated to increase the risk of metabolic syndrome and CVD, such as subclinical cardiac remodeling and stroke. However, until now the association between drinking large amounts of carbonated beverages and fatal CVD, or out-of-hospital cardiac arrests (OHCA) of cardiac origin, was unclear.”
The study compared the age-adjusted incidence of OHCAs to the consumption of various beverages per person between 2005 and 2011 in the 47 prefectures of Japan. It included 797 422 patients who had OHCAs of cardiac and non-cardiac origin from the All-Japan Utstein Registry of the Fire and Disaster Management Agency. Data on the consumption of the various beverages per person was obtained from the Ministry of Health, Labour and Welfare of Japan, using expenditure on beverages as a proxy measure.
The analysis focused on the 785 591 OHCA cases that received resuscitation, of which 435 064 (55.4%) were of cardiac origin and 350 527 (44.6%) were of non-cardiac origin. Those of non-cardiac origin included cerebrovascular disease, respiratory disease, malignant tumour, and exogenous disease (4.8%, 6.1%, 3.5%, and 18.9%, respectively).
The researchers found that expenditures on carbonated beverages were significantly associated with OHCAs of cardiac (r=0.30, p=0.04) (Figure 1), but not non-cardiac origin (r=-0.03, p=0.8).
Expenditures on other beverages, including green tea, black tea, coffee, cocoa, fruit or vegetable juice, fermented milk beverage, milk and mineral water were not significantly associated with OHCAs of cardiac origin.
“Carbonated beverage consumption was significantly and positively associated with OHCAs of cardiac origin in Japan, indicating that beverage habits may have an impact on fatal CVD,” said Professor Saku. “The acid in carbonated beverages might play an important role in this association.”
Professor Saku concluded: “Our data on carbonated beverage consumption is based on expenditure and the association with OHCA is not causal. But the findings do indicate that limiting consumption of carbonated beverages could be beneficial for health.”
Figure 1: Association between incidence of OHCA of cardiac origin and consumption of carbonated beverages
(data from 47 prefectures in Japan）
1Professor Saku will present the abstract ‘Carbonated beverages are associated with out-of-hospital cardiac arrests of cardiac origin: from the All-Japan Utstein Registry’ at 08:45 during:
• Registry II – Interventions / Acute cardiovascular care on Tuesday 1 September at 08:30 in St James Park (The Hub)
Notes to editor
SOURCES OF FUNDING: None.
DISCLOSURES: KS has an Endowed Department of “Advanced Therapeutics for Cardiovascular Disease” supported by Boston Scientific Japan Co. LTD, Japan Medtronic Co. LTD, Japan Lifeline Co. LTD, Nihon Kohden Co. LTD, and St. Jude Medical Japan Co. LTD (these 5 companies sell products related to OHCA: AED etc.). KS is a Director of the Nonprofit Organization Clinical and Applied Science, Fukuoka, Japan.
ESC Press Office
For background information or assistance, please contact the ESC Press Office.
For independent comment on site or interviews, please contact the ESC spokesperson coordinator: +44 7785 467 947
About the European Society of Cardiology
The European Society of Cardiology (ESC) represents more than 90 000 cardiology professionals across Europe and worldwide. Its mission is to reduce the burden of cardiovascular disease in Europe.
About ESC Congress 2015
ESC Congress is the world’s largest and most influential cardiovascular event contributing to global awareness of the latest clinical trials and breakthrough discoveries. ESC Congress 2015 takes place 29 August to 2 September at ExCel London in London, UK. Access the scientific programme. More information is available from the ESC Press Office at firstname.lastname@example.org.
To access all the scientific resources from the sessions during the congress, visit ESC Congress 365.
This press release accompanies both a presentation and an ESC press conference at the ESC Congress 2015. Edited by the ESC from material supplied by the investigators themselves, this press release does not necessarily reflect the opinion of the European Society of Cardiology. The content of the press release has been approved by the presenter.